glp 1 being discontinued Understanding GLP-1s and their dynamic marketplace and workplace trends Coming off GLP 1s |

As we look ahead to 2025, the upward trend in GLP-1 utilization signifies a pivotal shift in both patient care and employer strategies

Evaluation of activity of putative superoxide dismutase mimics: direct analysis by stopped-flow kinetics

TrkB expression is higher in iSPNs than their counterpart, dSPNs 49 , indicating their higher vulnerability to TrkB signalling alteration

Both individual and class action cases are being filed in multiple states, alleging that Novo Nordisk, the manufacturer of Ozempic, failed to adequately warn patients and healthcare providers about the potential risk of serious vision complications